Clinical features of patients infected with novel coronavirus in Wuhan, China. Lancet ; : Nature ; : Production of lymphokine-like factors cytokines by simian virus infected and simian virus transformed cells. Am J Pathol ; 80 1 : Chemokine receptors. Cytokine Growth Factor Rev ; 25— Nomenclature for clusters of differentiation CD of antigens defined on human leukocyte populations. Bull World Health Organ ; 62 5 : Monoclonal antibodies to human cell surface antigens.
Curr Protoc Immunol ; 80 1 : A. Durand PM, Ramsey G. The nature of programmed cell death. Biol Theory ; 30— Nat Immunol ; Immunol Lett ; Immunity ; S 20 Chen Z, John Wherry E. Nat Rev Immunol ; 20 9 : Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. J Clin Virol ; 58 4 : Increased glycoprotein branching hinders direct T cell interactions with APCs and decreases TCR signaling to promote poor sensitivity to antigens While increased expression of IL produced by TAMs has been correlated with the progression of certain cancers including non-small cell lung carcinoma, the role of IL in promoting CRC is not fully understood as it displays both protective and inflammatory roles — Programmed death 1 PD-1 is expressed on the surface of T cells and interacts with PD-L1, a ligand mainly expressed by macrophages, activated DCs and cancer cells Immunotherapy utilizing anti-PD-1 or anti-CTLA4 monoclonal antibodies is effective in fighting the progression of various cancers, and the intestinal microbiota may influence whether certain individuals respond more positively to therapy , For instance, increased levels of Akkermansia muciniphila , a commensal bacterium, were observed in patients who favorably reacted to treatment While much has been done to determine how APCs interact with T cells, several aspects should be expanded.
First, how bacteria influence APC interactions with immune cells to combat microbial infections should be further investigated. The interplay between microbiota-derived signaling and the onset of cancers also requires better understanding. Although not widely covered in this review, potential immunotherapies regarding altering APC or microbiota function should be studied. Likewise, a better understanding of how tumors develop strategies to take advantage of immune cells to promote tumorigenesis and dampen T cell responses, especially regarding the PD-1 system, is required.
Lastly, more investigation is needed to determine how factors derived from the microbiota, including SCFAs, and intestinal epithelial cells shape APC and immune cell interactions. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Adaptive immunity. J Allergy Clin. Immunological decision-making: how does the immune system decide to mount a helper T-cell response? TH2 cell development and function. Nat Rev Immunol. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol Baltim Md PubMed Abstract Google Scholar. Interferon-gamma at the crossroads of tumor immune surveillance or evasion.
Front Immunol. Annu Rev Immunol. In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell cooperativity.
Adaptive immune features of natural killer cells. Madera S, Sun JC. Cutting edge: stage-specific requirement of IL for antiviral NK cell expansion. Innate immunity. Allergy Clin Immunol. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.
Cold Spring Harb Perspect Biol. Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta. BMC Cell Biol. Trends Immunol. Toll-like receptors: critical proteins linking innate and acquired immunity. Semin Immunol. J Exp Med.
J Biol Chem. Burgdorf S, Kurts C. Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Leahy DJ. A structural view of CD4 and CD8. The role of dendritic cells in T cell activation. Immunol Cell Biol. Molecular mechanisms of t cells activation by dendritic cells in autoimmune diseases.
Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Intestinal Interleukin receptor signaling mediates reciprocal control of the gut microbiota and autoimmune inflammation. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
Intestinal antigen-presenting cells: key regulators of immune homeostasis and inflammation. Am J Pathol. Macrophages in intestinal homeostasis and inflammation. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17—producing T cell responses.
Nat Immunol. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.
Generation of gut-homing IgA-secreting b cells by intestinal dendritic cells. The genetics of inflammatory bowel disease. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin production in human memory T cells.
IL is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Liver Physiol. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. Am J Gastroenterol Suppl.
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 IL23 for the treatment of Crohn's disease. Exp Opin Invest Drugs. Secukinumab, a human anti-ILA monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.
InterleukinIndependent IL production regulates intestinal epithelial permeability. Differential roles for interleukin and interleukin in intestinal immunoregulation. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis.
Induction of Intestinal Th17 cells by segmented filamentous bacteria. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses.
Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Intestinal monocyte-derived macrophages control commensal-specific Th17 responses. Cell Rep. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Gut microbiota species can provoke both inflammatory and tolerogenic immune responses in human dendritic cells mediated by retinoic acid receptor alpha ligation. Sci Rep. Homeostatic IL receptor signaling limits Th17 response through ILmediated containment of commensal microbiota.
ILA-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria. Mucosal Immunol. Induction and molecular signature of pathogenic TH17 cells.
Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Activation of Gpra, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Peripheral education of the immune system by colonic commensal microbiota. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Withers DR. Innate lymphoid cell regulation of adaptive immunity. Microbiota-Induced TNF-like Ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal t cell activation during colitis.
Blander JM, Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. McClure R, Massari, P. TLR-dependent human mucosal epithelial cell responses to microbial pathogens. Role of the innate immune system in host defence against bacterial infections: focus on the Toll-like receptors. J Intern Med. Re F, Strominger JL. Motility as an intestinal colonization factor for campylobacter jejuni. In addition to TCR binding to antigen-loaded MHC, both helper T cells and cytotoxic T cells require a number of secondary signals to become activated and respond to the threat.
In the case of helper T cells, the first of these is provided by CD This process leads to the production of many millions of T cells that recognise the antigen. This molecule competes with CD28 for B7 and so reduces activation signals to the T cell and winds down the immune response. T cells must recognise foreign antigen strongly and specifically to mount an effective immune response and those that do are given survival signals by several molecules, including ICOS , BB and OX These molecules are found on the T-cell surface and are stimulated by their respective ligands which are typically found on APCs.
Likewise, their respective ligands are only expressed on APCs following pathogen recognition. This is important because it ensures T cells are only activated by APCs which have encountered a pathogen and responded. At present, the vaccine regimens used in human clinical trials for HIV and malaria include prime-boost immunization with plasmid DNA immunization followed by boosting with replication-deficient adenovirus or modified vaccinia virus.
It is hoped that with improved capacity to measure antigen-specific T cell responses, these initial clinical studies should be helpful in defining immune correlates of protection that would allow further refinement and optimization of future vaccines.
It is important to consider the issue of vaccine-induced systemic versus mucosal T cell immunity. This is a crucial topic that merits far more detailed discussion in a separate review.
Nevertheless, a few questions should be raised about mucosal and systemic responses in the context of vaccination. Perhaps the 'central' question is whether a vaccine must be administered mucosally for protection against a mucosal infection or whether systemic immunization will also work. Some studies have suggested that mucosal delivery is necessary for optimal mucosal immunity, whereas others have documented excellent protection against mucosal challenge after parenteral immunization in a primate model of HIV infection.
Clearly, the requirement for a mucosal- versus systemic-based vaccine is likely to vary depending on the pathogen. Overall, the potential importance of mucosal immune responses in mediating protection against infection raises specific questions about systemic and mucosal effector and memory T cells. For example, are qualitatively different effector T cells induced depending on the route of immunization?
Will these cells differ in effector function and potential to generate memory T cells? Is the memory differentiation program same or different after mucosal versus systemic immunization? Can memory T cells persist at mucosal sites? If so, are cytokines like IL and IL-7 involved in mucosal immunity, as they are in the maintenance of systemic memory T cells?
Or will mucosal immunity be more dependent on antigen or another cytokine? In addition, do memory T cells move back and forth between mucosal and systemic sites? These are just a few of the many salient questions that need to be addressed about mucosal versus systemic T cell immunity.
An understanding of these issues is essential for rational design of T cell—based vaccines. O'Garra, A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 , — Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Wong, P. Antigen-independent CD8 T cell proliferation.
Kaech, S. Lee, W. Gett, A. T cell fitness determined by signal strength. Lanzavecchia, A. Progressive differentiation and selection of the fittest in the immune response. Iezzi, G. The duration of antigenic stimulation determines the fate of naive and effector T cells.
Immunity 8 , 89—95 Gudmundsdottir, H. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. Jelley-Gibbs, D. Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation.
Wu, C. Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivo. Molecular and functional profiling of memory CD8 T cell differentiation. Cell , — Murphy, K. Signaling and transcription in T helper development.
Agarwal, S. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9 , — Szabo, S. A novel transcription factor, T-bet, directs TH1 lineage commitment. Mullen, A. Science , — Lee, G. Immunity 14 , — Foulds, K. CD4 and CD8 T cells are intrinsically different in their proliferative responses.
0コメント